Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways

Although great progress has been made in the early diagnosis and targeted therapy of lung adenocarcinoma (LUAD), the survival of patients with LUAD remains unsatisfactory. There is an urgent requirement for new biomarkers to guide the diagnosis, prognosis and treatment of LUAD. Following an initial...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Leng, Yuanxiu, Dong, Yudi, Song, Yongxiang, Wu, Qiaoyuan, Jiang, Ni, Dong, Hui, Chen, Fang, Luo, Qing, Cheng, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641803/
https://www.ncbi.nlm.nih.gov/pubmed/36420081
http://dx.doi.org/10.3892/ol.2022.13561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641803/
https://www.ncbi.nlm.nih.gov/pubmed/36420081
http://dx.doi.org/10.3892/ol.2022.13561

Ejemplares similares